Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biodesix (BDSX) Long-Term Debt Issuances (2019 - 2022)

Biodesix's Long-Term Debt Issuances history spans 4 years, with the latest figure at $30.0 million for Q4 2022.

  • For Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $30.0 million; the TTM value through Dec 2025 reached $30.0 million, changed N/A, while the annual FY2025 figure was $10.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $30.0 million in Q4 2022 per BDSX's latest filing, up from $15.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $30.0 million in Q1 2021 to a low of -$9.9 million in Q3 2020.
  • Average Long-Term Debt Issuances over 4 years is $9.1 million, with a median of $6.5 million recorded in 2020.
  • The largest YoY upside for Long-Term Debt Issuances was 19129.49% in 2022 against a maximum downside of 99.66% in 2022.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $3.0 million in 2019, then soared by 224.24% to $9.9 million in 2020, then tumbled by 99.21% to $78000.0 in 2021, then soared by 38361.54% to $30.0 million in 2022.
  • Per Business Quant, the three most recent readings for BDSX's Long-Term Debt Issuances are $30.0 million (Q4 2022), $15.0 million (Q2 2022), and $103000.0 (Q1 2022).